Medinotec reported revenue of $2.65M and net income of $0.22M for the quarter ended May 2026, up 24.2% year over year. This income statement covers 18 quarters of results from Feb 2022 through May 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Feb2022 | May2022 | Aug2022 | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 | May2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||
| Revenue | 0.59M | 0.20M | 0.14M | 0.39M | 0.28M | 0.42M | 0.35M | 2.00M | 2.25M | 1.25M | 1.80M | 2.57M | 3.53M | 2.13M | 3.24M | 2.54M | 1.82M | 2.65M |
| Cost of RevenueCost of Rev | 0.59M | 0.09M | 0.05M | 0.16M | 0.12M | 0.10M | 0.06M | 1.14M | 1.28M | 0.65M | 0.97M | 1.52M | 1.18M | 1.22M | 1.23M | 1.19M | 0.97M | 1.34M |
| Gross Profit | 0.46M | 0.11M | 0.09M | 0.22M | 0.16M | 0.32M | 0.29M | 0.86M | 0.97M | 0.60M | 0.83M | 1.04M | 2.34M | 0.91M | 2.00M | 1.35M | 0.85M | 1.31M |
| Operating items | ||||||||||||||||||
| Research & DevelopmentR&D | 0.03M | -0.03M | 0.02M | 0.02M | -0.13M | -0.05M | 0.03M | 0.04M | -0.20M | -0.02M | 0.02M | 0.07M | 0.02M | 0.05M | 0.67M | 0.34M | 0.45M | 0.50M |
| Selling, General & AdministrativeSG&A | 0.50M | -0.09M | 0.21M | 0.16M | -1.11M | -0.22M | 0.18M | 0.55M | -2.62M | -0.28M | 0.35M | 0.38M | 0.34M | 0.56M | 0.73M | 0.44M | 0.59M | 0.59M |
| Other Operating ExpensesOther Opex | 0.11M | -0.04M | 0.02M | 0.02M | -0.20M | -0.01M | 0.02M | 0.01M | -0.14M | -0.03M | -0.77M | -0.96M | -0.75M | -1.24M | -2.87M | -1.57M | -2.15M | -2.22M |
| Operating ExpensesOpex | 0.65M | -0.16M | 0.26M | 0.20M | -1.44M | -0.28M | 0.23M | 0.61M | -2.96M | -0.33M | -0.40M | -0.51M | -0.38M | -0.64M | -1.47M | -0.79M | -1.12M | -1.13M |
| Operating IncomeOp. Inc | -0.19M | -0.05M | -0.17M | 0.03M | -0.04M | 0.04M | 0.06M | 0.26M | 0.25M | 0.27M | 0.44M | 0.53M | 1.96M | 0.28M | 0.53M | 0.55M | -0.26M | 0.18M |
| EBIT | -0.19M | -0.05M | -0.17M | 0.03M | -0.04M | 0.04M | 0.06M | 0.26M | 0.25M | 0.27M | 0.44M | 0.53M | 1.96M | 0.28M | 0.53M | 0.55M | -0.26M | 0.18M |
| Non-operating items | ||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | -0.04M | -0.05M | 0.06M | -0.39M | -0.07M | -0.07M | -0.07M | -0.07M | 0.06M | 0.05M | 0.04M | 0.03M | 0.03M | 0.04M | 0.01M | 0.01M | 0.01M |
| Interest & Investment IncomeInt & Inv Inc | 30.00 | 62.00 | 52.00 | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.02M | 0.01M | -0.04M | 819.00 | 0.04M | 0.02M | 0.02M | 0.02M |
| Other Non Operating IncomeOther Non Op Inc. | 0.00M | 0.01M | 0.01M | 0.01M | 0.03M | 0.03M | -0.03M | -0.01M | 0.01M | 0.00M | 0.01M | -0.00M | -0.01M | 0.02M | 0.01M | -0.02M | -0.02M | 0.02M |
| Non Operating IncomeNon Op. Inc. | 0.00M | -0.04M | -0.05M | -0.04M | -0.03M | -0.02M | -0.09M | -0.69M | -0.06M | -0.06M | -0.03M | -0.05M | -0.04M | -0.01M | 0.01M | -0.01M | -0.01M | 0.03M |
| Net income details | ||||||||||||||||||
| EBT | -0.19M | -0.08M | -0.22M | -0.02M | -0.07M | 0.02M | -0.03M | -0.43M | 0.19M | 0.21M | 0.41M | 0.48M | 1.92M | 0.26M | 0.54M | 0.54M | -0.27M | 0.21M |
| Tax ProvisionsTaxes | -0.07M | -0.04M | 0.00M | 0.01M | 0.06M | -0.21M | 0.13M | 0.11M | 0.15M | -1.28M | -0.26M | 0.19M | 0.01M | 0.19M | ||||
| Profit After TaxPAT | -0.12M | -0.06M | -0.19M | -0.05M | -0.06M | 0.07M | -0.06M | -0.49M | 0.10M | 0.09M | 0.28M | 0.31M | 1.48M | 0.11M | 0.36M | 0.66M | 0.21M | 0.22M |
| Income from Non-Controlling InterestsInc. Minority | -0.18M | -0.16M | ||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.12M | -0.08M | -0.22M | 0.02M | -0.07M | 0.02M | -0.04M | -0.49M | 0.40M | 0.09M | 0.29M | 0.33M | 3.21M | 0.53M | 0.34M | 0.53M | -0.47M | 0.21M |
| Consolidated Net IncomeConsol Net Inc. | -0.12M | -0.08M | -0.22M | 0.02M | -0.07M | 0.02M | -0.04M | -0.49M | 0.40M | 0.09M | 0.29M | 0.33M | 3.21M | 0.53M | 0.34M | 0.53M | -0.47M | 0.21M |
| Income towards Parent CompanyParent Net Inc | -0.12M | -0.08M | -0.22M | 0.02M | -0.07M | 0.02M | -0.04M | -0.49M | 0.40M | 0.09M | 0.29M | 0.33M | 3.21M | 0.53M | 0.34M | 0.53M | -0.47M | 0.21M |
| Net Income towards Common StockholdersNet Income | -0.12M | -0.08M | -0.22M | 0.02M | -0.07M | 0.02M | -0.04M | -0.49M | 0.40M | 0.09M | 0.29M | 0.33M | 3.21M | 0.53M | 0.34M | 0.53M | -0.47M | 0.21M |
| Additional items | ||||||||||||||||||
| EPS (Basic) | -0.01 | 0.00 | 0.00 | -0.04 | 0.03 | 0.01 | 0.03 | 0.03 | 0.27 | 0.04 | 0.03 | 0.05 | -0.04 | 0.02 | ||||
| Shares Outstanding | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.76M | 11.76M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 10.00M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.73M | 11.76M | 11.76M | 11.76M | 11.76M | 11.76M | ||
| EBITDA | -0.19M | -0.05M | -0.17M | 0.03M | -0.04M | 0.04M | 0.06M | 0.26M | 0.25M | 0.27M | 0.44M | 0.53M | 1.96M | 0.28M | 0.53M | 0.55M | -0.26M | 0.18M |
| Interest ExpensesInt Expense | 0.01M | -0.04M | -0.05M | 0.06M | -0.39M | -0.07M | -0.07M | -0.07M | -0.07M | 0.06M | 0.05M | 0.04M | 0.03M | 0.03M | 0.04M | 0.01M | 0.01M | 0.01M |
| Tax Rate | 34.39% | 230.87% | 9.69% | -38.76% | -14.68% | -114.12% | 59.28% | 27.33% | 30.94% | -66.70% | -100.03% | 36.13% | 2.49% | -70.86% |